28 March 2017Americas

EPO to grant UC, Berkeley CRISPR patent

The European Patent Office (EPO) has revealed its intention to grant a patent covering the CRISPR gene-editing technology to the University of California, Berkeley, the University of Vienna, and inventor Emmanuelle Charpentier.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UC Berkeley gets $54k for T-cell patent NFT

17 June 2021 The University of California Berkeley has sold a non-fungible token based on patent disclosures for Nobel Prize-winning cancer immunotherapies research at an online auction, netting approximately $54,360 from the sale.

Americas

UC Berkeley auctions Nobel Prize invention materials as NFTs

1 June 2021 A non-fungible token for a Nobel Prize-winning cancer immunotherapy invention has been minted ahead of an auction tomorrow arranged by the University of California, Berkeley.

Europe

UC Berkeley loses CRISPR patent at EPO

25 May 2021 The University of California Berkeley has lost a CRISPR patent in Europe in the latest twist in the long-running IP saga over the gene-editing technology.

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

EPO to grant UC, Berkeley CRISPR patent

More on this story

Editor's picks

Editor's picks

More features